Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of a new “GENEROUS” Center for Medicare and Medicaid Innovation model to implement “most favored nation” drug price controls:

“While the Council for Citizens Against Government Waste supports efforts to lower costs and improve access to care, the Affordable Care Act’s Center for Medicare and Medicaid Innovation’s (CMMI) sweeping policy change to implement most favored nation drug price controls is the wrong approach. The so-called Innovation Center has a track record of disrupting patient and provider care and access, operating without adequate transparency and oversight, and wasting $5.4 billion from 2011-2020. Integrating CMMI’s abysmal track record with importing price controls from countries with socialized medicine is a terrible combination that will fail to reduce prices, stifle innovation, and end badly for taxpayers. There is nothing ‘GENEROUS’ about the CMMI model other than how much money it will waste.”

“Greater oversight and guardrails on CMMI’s authority are essential, and the American people agree. CCAGW’s October 2025 national survey of 1,600 voters found that a bipartisan 76 percent of voters support expanded oversight of CMMI, and 29 percent believe CMMI’s $10 billion-per-decade budget is an appropriate use of taxpayer dollars.”

“CMMI’s new proposal moves even further in the wrong direction. CCAGW again urges Congress to review CMMI’s funding, establish meaningful guardrails, and ensure that CMMI does not move forward with this deeply flawed proposal given its history of failure and wasteful spending.”

For additional information, please visit our website here: https://www.ccagw.org/cmmi

The Council for Citizens Against Government Waste is the lobbying arm of Citizens Against Government Waste, the nation’s largest nonpartisan, nonprofit organization dedicated to eliminating waste, fraud, abuse, and mismanagement in government.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251107170775/en/

CMMI sweeping policy change to implement most favored nation drug price controls is the wrong approach.